Bivin & Associates’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$817K Sell
3,910
-1,385
-26% -$309K 0.88% 42
2022
Q1
$1.17M Buy
5,295
+1,241
+31% +$262K 1.07% 19
2021
Q4
$948K Buy
+4,054
New +$1M 0.83% 40

Other funds holding ALB

Bivin & Associates's ALB Position: Q2 2022 in Review

Bivin & Associates reduced its Albemarle (ALB) stake by 26% in Q2 2022, selling an estimated $309K and leaving 3,910 shares worth $817K. The position accounts for 0.88% of the portfolio, ranked #42.

Bivin & Associates first reported a position in ALB in Q4 2021 and has held it in 3 quarters since. The position peaked at $1.17M in Q1 2022. 884 funds tracked by Wall St. Rank hold ALB as of Q2 2022.

  • Bivin & Associates held 3,910 shares of Albemarle worth $817K as of Q2 2022.
  • Bivin & Associates sold 1,385 Albemarle shares in Q2 2022, an estimated $309K.
  • Albemarle made up 0.88% of Bivin & Associates's portfolio in Q2 2022, its #42 holding.
  • Bivin & Associates first reported a position in Albemarle in Q4 2021 and has held it in 3 quarters since.
  • Bivin & Associates's Albemarle position peaked at $1.17M in Q1 2022.
  • 884 funds tracked by Wall St. Rank held Albemarle as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.